甲状腺相关眼病影像学研究进展  

Advances in imaging studies of thyroid-associated ophthalmopathy

作　　者：刘硕[1] 邢倩[1] Liu Shuo;Xing Qian(Department of Endocrinology and Metabolism,the First Affiliated Hospital of Dalian Medical University,Dalian 116021,China)

机构地区：[1]大连医科大学附属第一医院内分泌与代谢病科,大连116021

出　　处：《国际内分泌代谢杂志》2025年第1期27-30,共4页International Journal of Endocrinology and Metabolism

基　　金：辽宁省教育厅基本科研项目(LJKM20221282)。

摘　　要：甲状腺相关眼病(TAO)是Graves病最常见的甲状腺外表现。TAO活动性及严重程度的评估决定治疗方案的选择及预后。计算机断层扫描(CT)、核磁共振成像(MRI)、眼眶超声(US)、眼部光学相干断层扫描(OCT)以及基于影像学人工智能(AI)等方法经常被用于评价TAO病情。此外,放射性元素锝-二乙烯三胺五乙酸-单光子发射计算机断层扫描(^(99m)Tc^(m)-DTPA SPECT)及正电子发射断层扫描(PET)-CT/MRI等功能影像学对评估TAO有其特殊价值。现主要讨论目前影像学在评估TAO活动性及严重程度方面的作用,并阐述其在预测和监测治疗反应方面的应用价值。Thyroid-associated ophthalmopathy(TAO)is the most common extra-thyroidal manifestation of Graves′disease.The mainstay of TAO management relied heavily on accurate assessment of its activity and severity.Computed tomography(CT),magnetic resonance imaging(MRI),orbital ultrasound(US),and image-based artificial intelligence(AI),were often used to evaluate TAO.99mTc m-diethylen triamine penta-acetate(^(99m)Tc^(m)-DTPA),single-photon emission computed tomography(SPECT),and fluorodeoxyglucose positron emission tomography/computed tomography(FDG-PET/CT)were the potential measurements to assess the progress of TAO.This review summarized the current imaging in the assessment of activity and severity of TAO and explored their applications in predicting and monitoring therapeutic response.

关 键 词：甲状腺相关眼病 影像学 GRAVES病 

分 类 号：R58[医药卫生—内分泌]